Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

HLAVÁČKOVÁ Eva PILÁTOVÁ Kateřina FĚDOROVÁ Lenka MÚDRY Peter MAZÁNEK Pavel ŠTĚRBA Jaroslav ZDRAŽILOVÁ DUBSKÁ Lenka

Year of publication 2019
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Refractory and relapsing sarcoma and high-risk neuroblastoma show poor prognoses. Monocyte-derived dendritic cell anticancer vaccine could extend the treatment modalities in these patients. Pharmacotherapy prior to mononuclear cell harvest may influence the quality of manufactured dendritic cell product.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.